Bin Xie

Lung adenocarcinoma harboring concomitant EGFR mutation and EML4-ALK fusion that benefits from three kinds of tyrosine kinase inhibitors: a case report and literature review.

Yi-long Wu, Jin-Ji Yang, Xuchao Zhang, 2015, Clinical lung cancer.